Literature DB >> 29630699

Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy.

Zachary A Miller1, Lynne Rosenberg1, Miguel A Santos-Santos1, Melanie Stephens1, Isabel E Allen2, H Isabel Hubbard1, Averill Cantwell1, Maria Luisa Mandelli1, Lea T Grinberg1,3, William W Seeley1,3, Bruce L Miller1, Gil D Rabinovici1, Maria Luisa Gorno-Tempini1.   

Abstract

Importance: Increased prevalence of language-based learning disabilities (LDs) has been previously reported in patients with primary progressive aphasia (PPA). This study hypothesized that patients with focal neurodegenerative syndromes outside the language network, such as posterior cortical atrophy (PCA), would have a higher rate of nonlanguage LDs, congruent with their mainly visuospatial presentation. Objective: To investigate the prevalence and type of LD (language and/or mathematical and visuospatial) in a large cohort of patients with PCA compared with patients with logopenic variant PPA (lvPPA) and amnestic Alzheimer disease (AD). Design, Setting, and Participants: This case-control study reviewed 279 medical records from a university-based clinic and research center for patients with neurodegenerative diseases for LD history, including patients with PCA (n = 95), patients with lvPPA (n = 84), and a matched cohort with amnestic AD (n = 100). No records were excluded. The study compared cognitive and neuroimaging features of patients with PCA with and without LDs. A review of the records of patients presenting from March 1, 1999, to August 31, 2014, revealed 95 PCA cases and 84 lvPPA cases. Then 100 patients with amnestic AD from this same period were chosen for comparison, matching against the groups for age, sex, and disease severity. Data analysis was performed from September 8, 2013, to November 6, 2017. Main Outcomes and Measures: Prevalence of total LD history and prevalence of language and mathematical or visuospatial LD history across all cohorts.
Results: A total of 179 atypical AD cases (95 with PCA and 84 with lvPPA) and 100 disease control cases (amnestic AD) were included in the study. The groups were not statistically different for mean (SD) age at first visit (PCA, 61.9 [7.0] years; lvPPA, 65.1 [8.7] years; amnestic AD, 64.0 [12.6] years; P = .08), mean (SD) age at first symptom (PCA, 57.5 [7.0] years; lvPPA, 61.1 [9.0] years; amnestic AD, 59.6 [13.7] years; P = .06), or sex (PCA, 66.3% female; lvPPA, 56.0% female; amnestic AD, 57.0% female; P = .30) but differed on non-right-hand preference (PCA, 18.3%; lvPPA, 20.2%; amnestic AD, 7.7%; P = .04), race/ethnicity (PCA, 88.3% white; lvPPA, 99.0% white; amnestic AD, 80.0% white; P < .001), and mean (SD) educational level (PCA, 15.7 [3.2] years; lvPPA, 16.2 [3.3] years; amnestic AD, 14.8 [3.5] years; P = .02). A total of 18 of the 95 patients with PCA (18.9%) reported a history of LD, which is greater than the 3 of 100 patients (3.0%) in the amnestic AD cohort (P < .001) and the 10.0% expected rate in the general population (P = .007). In the PCA cohort, 13 of 95 patients (13.7%) had a nonlanguage mathematical and/or visuospatial LD; this rate was greater than that in the amnestic AD (1 of 100 [1.0%]; P < .001) and lvPPA (2 of 84 [2.4%]; P = .006) cohorts and greater than the 6.0% expected general population rate of mathematical LD (P = .003). Compared with the patients with PCA without LDs, the group with LDs had greater preservation of global cognition and a more right-lateralized pattern of atrophy. Conclusions and Relevance: Nonlanguage mathematical and visuospatial LDs were associated with focal, visuospatial predominant neurodegenerative clinical syndromes. This finding supports the hypothesis that neurodevelopmental differences in specific brain networks are associated with phenotypic manifestation of later-life neurodegenerative disease.

Entities:  

Mesh:

Year:  2018        PMID: 29630699      PMCID: PMC6027634          DOI: 10.1001/jamaneurol.2018.0395

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  45 in total

Review 1.  The complement system: an unexpected role in synaptic pruning during development and disease.

Authors:  Alexander H Stephan; Ben A Barres; Beth Stevens
Journal:  Annu Rev Neurosci       Date:  2012       Impact factor: 12.449

2.  Topographic representation of numerosity in the human parietal cortex.

Authors:  B M Harvey; B P Klein; N Petridou; S O Dumoulin
Journal:  Science       Date:  2013-09-06       Impact factor: 47.728

Review 3.  Developmental dyscalculia: prevalence and prognosis.

Authors:  R S Shalev; J Auerbach; O Manor; V Gross-Tsur
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

4.  Developmental dyscalculia is a familial learning disability.

Authors:  R S Shalev; O Manor; B Kerem; M Ayali; N Badichi; Y Friedlander; V Gross-Tsur
Journal:  J Learn Disabil       Date:  2001 Jan-Feb

5.  Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease.

Authors:  Mario F Mendez; Mehdi Ghajarania; Kent M Perryman
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 6.  How humans count: numerosity and the parietal cortex.

Authors:  Manuela Piazza; Véronique Izard
Journal:  Neuroscientist       Date:  2009-06       Impact factor: 7.519

Review 7.  Neurobiological underpinnings of math and reading learning disabilities.

Authors:  Sarit Ashkenazi; Jessica M Black; Daniel A Abrams; Fumiko Hoeft; Vinod Menon
Journal:  J Learn Disabil       Date:  2013-04-09

8.  Functional and structural alterations of the intraparietal sulcus in a developmental dyscalculia of genetic origin.

Authors:  Nicolas Molko; Arnaud Cachia; Denis Rivière; Jean François Mangin; Marie Bruandet; Denis Le Bihan; Laurent Cohen; Stanislas Dehaene
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

9.  Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart Review.

Authors:  Alon Seifan; Stephanie Assuras; Edward D Huey; Jesse Mez; Angeliki Tsapanou; Elise Caccappolo
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

10.  The enigma of Bálint's syndrome: neural substrates and cognitive deficits.

Authors:  Magdalena Chechlacz; Glyn W Humphreys
Journal:  Front Hum Neurosci       Date:  2014-03-07       Impact factor: 3.169

View more
  17 in total

1.  Latent atrophy factors related to phenotypical variants of posterior cortical atrophy.

Authors:  Colin Groot; B T Thomas Yeo; Jacob W Vogel; Xiuming Zhang; Nanbo Sun; Elizabeth C Mormino; Yolande A L Pijnenburg; Bruce L Miller; Howard J Rosen; Renaud La Joie; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici; Rik Ossenkoppele
Journal:  Neurology       Date:  2020-07-16       Impact factor: 9.910

Review 2.  The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Authors:  Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois
Journal:  Nat Rev Neurosci       Date:  2021-11-23       Impact factor: 34.870

3.  Case Study 1: A 55-Year-Old Woman With Progressive Cognitive, Perceptual, and Motor Impairments.

Authors:  Scott M McGinnis; Andrew M Stern; Jared K Woods; Matthew Torre; Mel B Feany; Michael B Miller; David A Silbersweig; Seth A Gale; Kirk R Daffner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-11-12       Impact factor: 2.198

Review 4.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 5.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

Review 6.  New insights into atypical Alzheimer's disease in the era of biomarkers.

Authors:  Jonathan Graff-Radford; Keir X X Yong; Liana G Apostolova; Femke H Bouwman; Maria Carrillo; Bradford C Dickerson; Gil D Rabinovici; Jonathan M Schott; David T Jones; Melissa E Murray
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

Review 7.  Considering learning disabilities and attention-deficit hyperactivity disorder when assessing for neurodegenerative disease.

Authors:  Mary K Colvin; Janet C Sherman
Journal:  Neurol Clin Pract       Date:  2020-12

8.  Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Orit H Lesman-Segev; Suzanne L Baker; Lauren Edwards; Leonardo Iaccarino; David N Soleimani-Meigooni; Taylor Mellinger; Mustafa Janabi; Zachary A Miller; David C Perry; Julie Pham; Amelia Strom; Maria Luisa Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Neurology       Date:  2020-12-01       Impact factor: 9.910

9.  Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.

Authors:  Colin Groot; Michel J Grothe; Shubhabrata Mukherjee; Irina Jelistratova; Iris Jansen; Anna Catharina van Loenhoud; Shannon L Risacher; Andrew J Saykin; Christine L Mac Donald; Jesse Mez; Emily H Trittschuh; Gregor Gryglewski; Rupert Lanzenberger; Yolande A L Pijnenburg; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier; Paul K Crane; Rik Ossenkoppele
Journal:  Neuroimage Clin       Date:  2021-04-03       Impact factor: 4.881

Review 10.  Update on posterior cortical atrophy.

Authors:  Samantha K Holden; Brianne M Bettcher; Victoria S Pelak
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 6.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.